ClinicalTrials.gg
Enrolling by invitationNCT07290725CCV UCMTUpdated Mar 30, 2026

Cross-cultural Adaptation and Translation Validation of the iADH Universal Case Mix Tool (UCMT).

An observational study in Dentistry, sponsored by Sigmund Freud PrivatUniversitat. Enrolling by invitation at 1 site in Austria. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by Sigmund Freud PrivatUniversitat · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Sex
All
01

Study summary

This study aims to translate, culturally adapt, and validate the iADH Universal Case Mix Tool (UCMT) for dental care professionals working with people with disabilities.

The study will assess linguistic accuracy, applicability, and reliability/validity of the German, Spanish and Portuguese version of the instrument.

Read the detailed description

This study is a multicentre, non-interventional methodological study aimed at translating, culturally adapting, and validating the iADH Universal case mix tool (UCMT) for use by dental care professionals working with people living with disabilities, following international guidelines for cross-cultural adaptation of measurement instruments. The translation and cultural adaptation process will include forward and backward translations of the original UCMT (English) to German, Spanish and Portuguese. Two independent forward translations will be performed for each language, followed by reconciliation into a single version, based on semantic equivalence, clarity and cultural appropriateness. Blinded backward translations into English will then be conducted to ensure conceptual consistency with the original instrument. A panel of experts, composed of dental experts and linguistic professionals fluent in both languages will review all translated versions using a Delphi approach. Later, the adapted instruments will be reviewed by the original UCMT developers for the final approval. Consent Validity Index (CVI) of the translated UCMT will be evaluated through expert ratings and cognitive interviews with dental professionals experienced in special care dentistry. Following the experts' validation, a pilot reliability phase will be conducted using standardised online clinical cases developed for the original versions of the UCMT. Participating raters will complete an online questionnaire using the translated UCMT. Intra and interrater agreement will be assessed to evaluate consistency of the translated instrument in a simulated clinical scenario. This study does not involve real patients of the collection of sensitive personal data.

02

Conditions studied

  • Dentistry

Keywords

  • special care dentistry
03

In context

Lead sponsor

Sigmund Freud PrivatUniversitat is the lead sponsor of 12 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Inclusion Criteria:

  • Special care dentist
  • Native in German, Spanish or Portuguese
  • Agree to participate, complete the instrument 2 times

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Special care dentist
  • Native in German, Spanish or Portuguese
  • Agree to participate, complete the instrument 2 times

Exclusion criteria

Exclusion Criteria:

  • Not meeting the inclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • special care dentists - spanish

    Special Care Dentistry Specialist, native Spanish speaker

  • Special care dentists - german

    Special Care Dentistry Specialist, native German speaker

  • Special care dentists - Portuguese

    Special Care Dentistry Specialist, native Portuguese speaker

06

What researchers measure

Primary outcomes

  1. Content validity of the translated UCMT

    Content validity of the UCMT will be assessed by a panel of multidisciplinary experts, assessing clarity, relevance and cultural appropriateness. Experts ratings will be used to calculate Content Validity Index (CVI) for the translated versions of the UCMT. Unit of measure: CVI (Range 0-1)

    Time frame: 1 week

Secondary outcomes

  1. Interrater agreement of the UCMT domains scores

    Interrater agreement will be assessed based on scores assigned to the seven domains of the UCMT in the original version and validation. Raters will independently evaluate standardised online cases using the translated versions of the UCMT. Agreement between raters will be quantified for each UCMT domain. Unit of measure: Interclass correlation coefficient (range 0-1)

    Time frame: 1 month

  2. Temporal stability (Test-retest) of UCMT domain scores

    Intrarater agreement (Temporal stability) will be assessed based on scores assigned to the seven domains of the UCMT in the original version and validation. Raters will independently evaluate standardised online cases using the translated versions of the UCMT on two occasions separated by 1-2 weeks . Agreement between these occasions will be quantified for each UCMT domain. Unit of measure: Interclass correlation coefficient (range 0-1)

    Time frame: 2 weeks

07

Study locations

1 site
  • SFU - Online questionnaire
    Vienna, State of Vienna 1020, Austria
08

References and documents

Publications

  • Mac Giolla Phadraig C, Faulks D, McGrath C, Dougall A, Molina G. Development and Content Validity of the International Association for Disability and Oral Health Universal Case Mix Tool: A Consensus Study. Community Dent Oral Epidemiol. 2025 Aug;53(4):402-412. doi: 10.1111/cdoe.13041. Epub 2025 Apr 30. PubMed 40304234 ↗

Individual participant data

Plan to share: No — Not necessary

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2025 to primary completion in Nov 2025, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2025
First posted
Dec 18, 2025
StartActual
Jun 1, 2025
Primary completionActual
Nov 1, 2025
CompletionEst.
Dec 2026
Last update
Mar 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07290725
Lead sponsor
Sigmund Freud PrivatUniversitat
Collaborators
University of Freiburg, University of Chile
Responsible party
Sebastian Veliz (DDS, Researcher, Sigmund Freud PrivatUniversitat) — Principal investigator
First posted
Dec 18, 2025
Start date
Jun 1, 2025
Primary completion
Nov 1, 2025
Completion
Dec 2026 (estimated)
Last update
Mar 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion